湖南城乡居民医保待遇出台新政 高血压糖尿病门诊药费可报销达7成

2019-12-12 刘银艳 华声在线

记者12日从湖南省医疗保障局了解到,湖南省已于日前出台《关于做好城乡居民高血压糖尿病门诊用药保障工作的实施意见》(以下简称《实施意见》),明确城乡居民高血压糖尿病“两病”参保患者在我省的协议基层医疗机构看门诊开降压药、降糖药,可进行医保报销,政策范围内支付比例可达70%。此举可让我省700多万城乡居民“两病”参保患者受益。《实施意见》明确,保障对象为参加我省城乡居民基本医疗保险(以下简称“居民医保

记者12日从湖南省医疗保障局了解到,湖南省已于日前出台《关于做好城乡居民高血压糖尿病门诊用药保障工作的实施意见》(以下简称《实施意见》),明确城乡居民高血压糖尿病“两病”参保患者在我省的协议基层医疗机构看门诊开降压药、降糖药,可进行医保报销,政策范围内支付比例可达70%。此举可让我省700多万城乡居民“两病”参保患者受益。

《实施意见》明确,保障对象为参加我省城乡居民基本医疗保险(以下简称“居民医保”)并需要采取药物治疗的“两病”患者。

“两病”参保患者门诊用药保障的就诊范围以协议基层医疗机构为依托,主要包括符合医保准入条件的乡镇卫生院、村卫生室、社区卫生服务中心(站)、高校医务室等。

“两病”参保患者门诊用药范围在国家基本医疗保险药品目录品种范围内选择确定,甲类药品、国家基本药物、集中招标采购中选药品不设自付比例,其他药品按照我省基本医疗保险药品目录规定的自付比例由参保人员个人先行支付后,再按照医保支付标准的有关规定纳入门诊医保基金支付范围,“两病”患者合并其他疾病门诊所需治疗性药品,按照医保药品目录管理政策规定使用。
 
“两病”参保患者在协议基层医疗卫生机构就诊时,由签约家庭医生开具的符合用药范围规定的降血压、降血糖药品费用,不设起付线,按照70%比例支付,高血压患者每年最高支付限额360元,糖尿病患者每年最高支付限额600元,通过普通门诊统筹基金支付。“两病”参保患者合并其他靶器官功能损害,达到特门疾病准入标准的,继续按照特门疾病管理,按照70%比例支付,每年最高支付限额1800元,通过特门疾病保障基金支付。

《实施意见》要求,适当放宽“两病”参保患者门诊配药时限,根据病情需要,可将一次处方医保用药量延长到4周(或1个月),对评估后符合要求的“两病”参保患者,可以一次开具12周以内相关药品。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2056832, encodeId=b0d5205683232, content=<a href='/topic/show?id=b06b4e69116' target=_blank style='color:#2F92EE;'>#居民医保#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47691, encryptionId=b06b4e69116, topicName=居民医保)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6da1120, createdName=lidong40, createdTime=Wed Feb 26 02:36:00 CST 2020, time=2020-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1440182, encodeId=50eb144018277, content=<a href='/topic/show?id=dd405036656' target=_blank style='color:#2F92EE;'>#待遇#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50366, encryptionId=dd405036656, topicName=待遇)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0c04702222, createdName=zjshifan_98647307, createdTime=Sat Dec 14 13:36:00 CST 2019, time=2019-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1446244, encodeId=cf711446244f2, content=<a href='/topic/show?id=f8cb8e958ae' target=_blank style='color:#2F92EE;'>#药费#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87958, encryptionId=f8cb8e958ae, topicName=药费)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=0Yy1x0ia6yKWyKUaG6Ja0UA&s=100&t=1564295847, createdBy=646f5195679, createdName=bshuang, createdTime=Sat Dec 14 13:36:00 CST 2019, time=2019-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1545779, encodeId=01c71545e79cf, content=<a href='/topic/show?id=8df5560640e' target=_blank style='color:#2F92EE;'>#报销#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56064, encryptionId=8df5560640e, topicName=报销)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=718013815880, createdName=ms705947299214030, createdTime=Sat Dec 14 13:36:00 CST 2019, time=2019-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1629071, encodeId=3eb616290e199, content=<a href='/topic/show?id=f400415907f' target=_blank style='color:#2F92EE;'>#城乡居民#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41590, encryptionId=f400415907f, topicName=城乡居民)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54d421278861, createdName=villahu, createdTime=Sat Dec 14 13:36:00 CST 2019, time=2019-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1042868, encodeId=3df91042868a5, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Fri Dec 13 01:36:00 CST 2019, time=2019-12-13, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2056832, encodeId=b0d5205683232, content=<a href='/topic/show?id=b06b4e69116' target=_blank style='color:#2F92EE;'>#居民医保#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47691, encryptionId=b06b4e69116, topicName=居民医保)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6da1120, createdName=lidong40, createdTime=Wed Feb 26 02:36:00 CST 2020, time=2020-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1440182, encodeId=50eb144018277, content=<a href='/topic/show?id=dd405036656' target=_blank style='color:#2F92EE;'>#待遇#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50366, encryptionId=dd405036656, topicName=待遇)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0c04702222, createdName=zjshifan_98647307, createdTime=Sat Dec 14 13:36:00 CST 2019, time=2019-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1446244, encodeId=cf711446244f2, content=<a href='/topic/show?id=f8cb8e958ae' target=_blank style='color:#2F92EE;'>#药费#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87958, encryptionId=f8cb8e958ae, topicName=药费)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=0Yy1x0ia6yKWyKUaG6Ja0UA&s=100&t=1564295847, createdBy=646f5195679, createdName=bshuang, createdTime=Sat Dec 14 13:36:00 CST 2019, time=2019-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1545779, encodeId=01c71545e79cf, content=<a href='/topic/show?id=8df5560640e' target=_blank style='color:#2F92EE;'>#报销#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56064, encryptionId=8df5560640e, topicName=报销)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=718013815880, createdName=ms705947299214030, createdTime=Sat Dec 14 13:36:00 CST 2019, time=2019-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1629071, encodeId=3eb616290e199, content=<a href='/topic/show?id=f400415907f' target=_blank style='color:#2F92EE;'>#城乡居民#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41590, encryptionId=f400415907f, topicName=城乡居民)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54d421278861, createdName=villahu, createdTime=Sat Dec 14 13:36:00 CST 2019, time=2019-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1042868, encodeId=3df91042868a5, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Fri Dec 13 01:36:00 CST 2019, time=2019-12-13, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2056832, encodeId=b0d5205683232, content=<a href='/topic/show?id=b06b4e69116' target=_blank style='color:#2F92EE;'>#居民医保#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47691, encryptionId=b06b4e69116, topicName=居民医保)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6da1120, createdName=lidong40, createdTime=Wed Feb 26 02:36:00 CST 2020, time=2020-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1440182, encodeId=50eb144018277, content=<a href='/topic/show?id=dd405036656' target=_blank style='color:#2F92EE;'>#待遇#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50366, encryptionId=dd405036656, topicName=待遇)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0c04702222, createdName=zjshifan_98647307, createdTime=Sat Dec 14 13:36:00 CST 2019, time=2019-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1446244, encodeId=cf711446244f2, content=<a href='/topic/show?id=f8cb8e958ae' target=_blank style='color:#2F92EE;'>#药费#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87958, encryptionId=f8cb8e958ae, topicName=药费)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=0Yy1x0ia6yKWyKUaG6Ja0UA&s=100&t=1564295847, createdBy=646f5195679, createdName=bshuang, createdTime=Sat Dec 14 13:36:00 CST 2019, time=2019-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1545779, encodeId=01c71545e79cf, content=<a href='/topic/show?id=8df5560640e' target=_blank style='color:#2F92EE;'>#报销#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56064, encryptionId=8df5560640e, topicName=报销)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=718013815880, createdName=ms705947299214030, createdTime=Sat Dec 14 13:36:00 CST 2019, time=2019-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1629071, encodeId=3eb616290e199, content=<a href='/topic/show?id=f400415907f' target=_blank style='color:#2F92EE;'>#城乡居民#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41590, encryptionId=f400415907f, topicName=城乡居民)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54d421278861, createdName=villahu, createdTime=Sat Dec 14 13:36:00 CST 2019, time=2019-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1042868, encodeId=3df91042868a5, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Fri Dec 13 01:36:00 CST 2019, time=2019-12-13, status=1, ipAttribution=)]
    2019-12-14 bshuang
  4. [GetPortalCommentsPageByObjectIdResponse(id=2056832, encodeId=b0d5205683232, content=<a href='/topic/show?id=b06b4e69116' target=_blank style='color:#2F92EE;'>#居民医保#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47691, encryptionId=b06b4e69116, topicName=居民医保)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6da1120, createdName=lidong40, createdTime=Wed Feb 26 02:36:00 CST 2020, time=2020-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1440182, encodeId=50eb144018277, content=<a href='/topic/show?id=dd405036656' target=_blank style='color:#2F92EE;'>#待遇#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50366, encryptionId=dd405036656, topicName=待遇)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0c04702222, createdName=zjshifan_98647307, createdTime=Sat Dec 14 13:36:00 CST 2019, time=2019-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1446244, encodeId=cf711446244f2, content=<a href='/topic/show?id=f8cb8e958ae' target=_blank style='color:#2F92EE;'>#药费#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87958, encryptionId=f8cb8e958ae, topicName=药费)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=0Yy1x0ia6yKWyKUaG6Ja0UA&s=100&t=1564295847, createdBy=646f5195679, createdName=bshuang, createdTime=Sat Dec 14 13:36:00 CST 2019, time=2019-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1545779, encodeId=01c71545e79cf, content=<a href='/topic/show?id=8df5560640e' target=_blank style='color:#2F92EE;'>#报销#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56064, encryptionId=8df5560640e, topicName=报销)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=718013815880, createdName=ms705947299214030, createdTime=Sat Dec 14 13:36:00 CST 2019, time=2019-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1629071, encodeId=3eb616290e199, content=<a href='/topic/show?id=f400415907f' target=_blank style='color:#2F92EE;'>#城乡居民#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41590, encryptionId=f400415907f, topicName=城乡居民)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54d421278861, createdName=villahu, createdTime=Sat Dec 14 13:36:00 CST 2019, time=2019-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1042868, encodeId=3df91042868a5, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Fri Dec 13 01:36:00 CST 2019, time=2019-12-13, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2056832, encodeId=b0d5205683232, content=<a href='/topic/show?id=b06b4e69116' target=_blank style='color:#2F92EE;'>#居民医保#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47691, encryptionId=b06b4e69116, topicName=居民医保)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6da1120, createdName=lidong40, createdTime=Wed Feb 26 02:36:00 CST 2020, time=2020-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1440182, encodeId=50eb144018277, content=<a href='/topic/show?id=dd405036656' target=_blank style='color:#2F92EE;'>#待遇#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50366, encryptionId=dd405036656, topicName=待遇)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0c04702222, createdName=zjshifan_98647307, createdTime=Sat Dec 14 13:36:00 CST 2019, time=2019-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1446244, encodeId=cf711446244f2, content=<a href='/topic/show?id=f8cb8e958ae' target=_blank style='color:#2F92EE;'>#药费#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87958, encryptionId=f8cb8e958ae, topicName=药费)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=0Yy1x0ia6yKWyKUaG6Ja0UA&s=100&t=1564295847, createdBy=646f5195679, createdName=bshuang, createdTime=Sat Dec 14 13:36:00 CST 2019, time=2019-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1545779, encodeId=01c71545e79cf, content=<a href='/topic/show?id=8df5560640e' target=_blank style='color:#2F92EE;'>#报销#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56064, encryptionId=8df5560640e, topicName=报销)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=718013815880, createdName=ms705947299214030, createdTime=Sat Dec 14 13:36:00 CST 2019, time=2019-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1629071, encodeId=3eb616290e199, content=<a href='/topic/show?id=f400415907f' target=_blank style='color:#2F92EE;'>#城乡居民#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41590, encryptionId=f400415907f, topicName=城乡居民)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54d421278861, createdName=villahu, createdTime=Sat Dec 14 13:36:00 CST 2019, time=2019-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1042868, encodeId=3df91042868a5, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Fri Dec 13 01:36:00 CST 2019, time=2019-12-13, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=2056832, encodeId=b0d5205683232, content=<a href='/topic/show?id=b06b4e69116' target=_blank style='color:#2F92EE;'>#居民医保#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47691, encryptionId=b06b4e69116, topicName=居民医保)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6da1120, createdName=lidong40, createdTime=Wed Feb 26 02:36:00 CST 2020, time=2020-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1440182, encodeId=50eb144018277, content=<a href='/topic/show?id=dd405036656' target=_blank style='color:#2F92EE;'>#待遇#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50366, encryptionId=dd405036656, topicName=待遇)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0c04702222, createdName=zjshifan_98647307, createdTime=Sat Dec 14 13:36:00 CST 2019, time=2019-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1446244, encodeId=cf711446244f2, content=<a href='/topic/show?id=f8cb8e958ae' target=_blank style='color:#2F92EE;'>#药费#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87958, encryptionId=f8cb8e958ae, topicName=药费)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=0Yy1x0ia6yKWyKUaG6Ja0UA&s=100&t=1564295847, createdBy=646f5195679, createdName=bshuang, createdTime=Sat Dec 14 13:36:00 CST 2019, time=2019-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1545779, encodeId=01c71545e79cf, content=<a href='/topic/show?id=8df5560640e' target=_blank style='color:#2F92EE;'>#报销#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56064, encryptionId=8df5560640e, topicName=报销)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=718013815880, createdName=ms705947299214030, createdTime=Sat Dec 14 13:36:00 CST 2019, time=2019-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1629071, encodeId=3eb616290e199, content=<a href='/topic/show?id=f400415907f' target=_blank style='color:#2F92EE;'>#城乡居民#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41590, encryptionId=f400415907f, topicName=城乡居民)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54d421278861, createdName=villahu, createdTime=Sat Dec 14 13:36:00 CST 2019, time=2019-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1042868, encodeId=3df91042868a5, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Fri Dec 13 01:36:00 CST 2019, time=2019-12-13, status=1, ipAttribution=)]
    2019-12-13 misszhang

    谢谢MedSci提供最新的资讯

    0

相关资讯

浙江城乡居民基本养老保险有新政策!明年起这些变化影响你我

近日,经浙江省委、省政府同意,省人力社保厅会同省财政厅印发《关于建立城乡居民基本养老保险待遇确定和基础养老金正常调整机制的实施意见》,对完善待遇确定机制、建立基础养老金正常调整机制、调整个人缴费档次等事项进行了明确。《实施意见》自2020年1月1日起实施。《实施意见》要求各地各有关部门切实把政策落实到位,随小布详细了解~完善待遇确定机制浙江城乡居民基本养老保险待遇由基础养老金、个人账户养老金和缴费

《关于做好2019年城乡居民基本医疗保障工作的通知》政策解读

5月13日,为贯彻落实2019年《政府工作报告》任务要求,全面推进完善统一的城乡居民基本医疗保险和大病保险制度,国家医疗保障局会同财政部印发了《关于做好2019年城乡居民基本医疗保障工作的通知》(医保发﹝2019﹞30号,以下简称《通知》),同时公布了其相关内容的政策解读。

湖南:提升城乡居民门诊医疗保障待遇水平

近日,湖南省医疗保障局、省财政厅、省卫生健康委员会联合印发《关于进一步完善城乡居民基本医疗保险门诊医疗保障政策的通知》,自2019年9月1日起,湖南省参保的城乡居民,在医保定点基层医疗机构进行普通门诊就诊时,待遇有了较大的提高。门诊医疗费用不设起付线,医保按70%比例支付《通知》指出,参保居民在协议基层医疗卫生机构就诊时,政策范围内门诊医疗费用不设起付线,支付比例70%。在年度最高支付限额以内,遵

医保局:城乡居民医保个人(家庭)账户取消不降低医保待遇

国家医保局日前发布的关于城乡居民基本医疗保险门诊保障政策的解读指出,城乡居民医保个人(家庭)账户取消并不会降低居民的医保待遇,而是通过推进门诊统筹进行替代。国家医保局会同财政部此前印发的《关于做好2019年城乡居民基本医疗保障工作的通知》提出,实行个人(家庭)账户的,应于2020年底前取消,向门诊统筹平稳过渡;已取消个人(家庭)账户的,不得恢复或变相设置。城乡居民基本医疗保险制度整合了原有的城镇居

北京提高城乡居民区属三级医疗机构住院报销比例

为增强居民医保的兜底保障功能,鼓励支持城乡居民区内就医,北京市医保局自2020年起将各区医院、区中医院等区属三级医疗机构住院报销比例提高到78%。同时,进一步扩大门诊首诊范围。11日,北京市医保局相关负责人表示,2018年北京市整合城镇居民基本医疗保险和新型农村合作医疗两项制度,率先构建了全市统筹、城乡统一的居民医保制度。城乡居民医保制度统一后待遇水平进一步提高:门诊实际补偿比例提高了5个百分点,

北京城乡居民医保明年起调整,三大变化值得关注

近日,北京市医疗保障局发布《关于调整城乡居民基本医疗保险筹资标准及相关政策的通知》,通知宣布,2020年起,医保政策将迎来新的调整。北京医保将会迎来哪些利好变化?健康时报记者进行了梳理。变化一:城乡居民人均财政补助每年增千元医保政策调整后,从2020年起,城乡老年人和学生儿童每年个人缴费标准由180元调整为300元,劳动年龄内居民每人每年由300元调整为520元。在医保补助方面,城乡居民人均财政补